Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Holbæk – page 34

621 clinical trials in Holbæk, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Holbæk at a glance
621
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

621 trials in Holbæk

Open in trial search

Title: Study of LP352 (bexicaserin) oral solution versus placebo for treating seizures in children and adults with Developmental and Epileptic Encephalopathies

Investigational
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bexicaserin hydrochloride
  • Sponsor:Longboard Pharmaceuticals Inc.

Influenza

Not recruiting

Study Comparing High-Dose vs. Standard-Dose Influenza Vaccine for Preventing Flu in Older Adults

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:65+ years · Healthy volunteers
  • Substances:Elasomeran
  • Sponsor:Gentofte Hospital

Coronavirus infection

Not recruiting

Study on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
  • Substances:Cilgavimab
  • Sponsor:AstraZeneca AB

Open angle glaucoma+1

Not recruiting

Study on Goblet Cell Density in Patients with Ocular Hypertension or Primary Open Angle Glaucoma Using Benzalkonium Chloride and Latanoprost Eye Drops

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Latanoprost
  • Sponsor:Rigshospitalet

HIV infection

Not recruiting

Study on the Safety and Effectiveness of Emtricitabine and Tenofovir Alafenamide for HIV-1 Prevention in Men and Transgender Women at Risk

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Emtricitabine
  • Sponsor:Gilead Sciences Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Fentanyl Citrate
  • Sponsor:Rigshospitalet

Study of GBS-NN/NN2 vaccine to prevent Group B streptococcus infection in healthy pregnant women: evaluating long-term immunity and booster dose safety during subsequent pregnancy

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:GBS-NN
  • Sponsor:Minervax ApS

Perinatal depression

Not recruiting

Study on Using Estradiol to Prevent Postpartum Depression in Women with a History of the Condition

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Estradiol
  • Sponsor:Rigshospitalet
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Ropivacaine Hydrochloride
  • Sponsor:Region Sjaelland

Diabetic nephropathy+2

Not recruiting

Study on Aspirin's Effect on Platelet Aggregation in Patients with Type 1 Diabetes, Atherosclerotic Cardiovascular Disease, and Diabetic Kidney Disease

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Acetylsalicylic Acid
  • Sponsor:Steno Diabetes Center Copenhagen

Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Sanofi Pasteur
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:MRNA-1345
  • Sponsor:Moderna Inc.

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Holbæk

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on heart failure prevention and innovative treatments for atrial fibrillation. Multiple trials are evaluating new therapeutic combinations and medications for improved patient outcomes.

  • Heart Failure Management
  • Stroke Prevention
  • Cardiac Arrest Treatment

Research includes novel approaches using baxdrostat and dapagliflozin combinations for heart failure risk reduction.

02 Kidney Disease Studies

Comprehensive research into chronic kidney disease treatments, particularly focusing on patients with concurrent hypertension. Studies examine innovative therapeutic approaches for non-diabetic kidney disease.

  • CKD Progression
  • Hemodialysis Treatments
  • Renal Function Protection

Trials investigate combined therapies to slow disease progression and improve patient outcomes.

03 Metabolic Disorders

Innovative trials addressing obesity management in different age groups, with special attention to adolescent populations. Studies also focus on diabetes treatment approaches.

  • Weight Management Therapies
  • Type 1 & 2 Diabetes
  • Metabolic Interventions

Research includes novel treatments with semaglutide for weight management in young populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.